Lantheus Holdings, Inc. (NASDAQ:LNTH) major shareholder Avista Capital Partners Gp, Ll sold 87,939 shares of Lantheus Holdings stock in a transaction on Monday, August 14th. The shares were sold at an average price of $17.40, for a total transaction of $1,530,138.60. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Major shareholders that own 10% or more of a company’s stock are required to disclose their transactions with the SEC.

Avista Capital Partners Gp, Ll also recently made the following trade(s):

  • On Wednesday, August 16th, Avista Capital Partners Gp, Ll sold 12,128 shares of Lantheus Holdings stock. The shares were sold at an average price of $17.05, for a total transaction of $206,782.40.
  • On Tuesday, August 15th, Avista Capital Partners Gp, Ll sold 40,779 shares of Lantheus Holdings stock. The shares were sold at an average price of $17.06, for a total transaction of $695,689.74.

Shares of Lantheus Holdings, Inc. (LNTH) traded down 6.82% during trading on Wednesday, hitting $15.70. 1,387,452 shares of the company’s stock were exchanged. The company has a market cap of $586.40 million, a P/E ratio of 21.45 and a beta of 0.91. Lantheus Holdings, Inc. has a 12-month low of $5.68 and a 12-month high of $20.45. The company has a 50-day moving average of $18.08 and a 200-day moving average of $14.43.

Lantheus Holdings (NASDAQ:LNTH) last issued its earnings results on Tuesday, August 1st. The medical equipment provider reported $0.42 EPS for the quarter, beating the Zacks’ consensus estimate of $0.24 by $0.18. The business had revenue of $88.83 million during the quarter, compared to analysts’ expectations of $80.56 million. Lantheus Holdings had a net margin of 8.44% and a negative return on equity of 37.47%. The company’s quarterly revenue was up 13.9% compared to the same quarter last year. During the same period in the prior year, the business earned $0.24 earnings per share. On average, equities analysts expect that Lantheus Holdings, Inc. will post $1.12 earnings per share for the current fiscal year.

TRADEMARK VIOLATION NOTICE: “Insider Selling: Lantheus Holdings, Inc. (LNTH) Major Shareholder Sells 87,939 Shares of Stock” was first posted by Watch List News and is the property of of Watch List News. If you are viewing this news story on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/insider-selling-lantheus-holdings-inc-lnth-major-shareholder-sells-87939-shares-of-stock/1496758.html.

Large investors have recently made changes to their positions in the stock. Highbridge Capital Management LLC purchased a new stake in shares of Lantheus Holdings during the fourth quarter worth about $237,000. IFP Advisors Inc purchased a new stake in shares of Lantheus Holdings during the first quarter worth about $231,000. LSV Asset Management raised its stake in shares of Lantheus Holdings by 18.8% in the first quarter. LSV Asset Management now owns 182,700 shares of the medical equipment provider’s stock worth $2,283,000 after buying an additional 28,900 shares in the last quarter. Capital One National Association raised its stake in shares of Lantheus Holdings by 7.7% in the first quarter. Capital One National Association now owns 69,050 shares of the medical equipment provider’s stock worth $863,000 after buying an additional 4,925 shares in the last quarter. Finally, Algert Global LLC purchased a new stake in shares of Lantheus Holdings during the first quarter worth about $357,000. 71.53% of the stock is owned by hedge funds and other institutional investors.

A number of brokerages have commented on LNTH. Zacks Investment Research raised shares of Lantheus Holdings from a “hold” rating to a “strong-buy” rating and set a $18.00 price objective for the company in a research note on Thursday, August 3rd. Credit Suisse Group lifted their price objective on shares of Lantheus Holdings from $14.00 to $19.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 2nd. Jefferies Group LLC reissued a “buy” rating and issued a $22.00 price objective (up from $18.00) on shares of Lantheus Holdings in a research note on Wednesday, August 2nd. Finally, Cantor Fitzgerald began coverage on shares of Lantheus Holdings in a research note on Monday, July 17th. They issued an “overweight” rating and a $22.00 price objective for the company. One investment analyst has rated the stock with a hold rating, three have given a buy rating and one has assigned a strong buy rating to the stock. Lantheus Holdings currently has an average rating of “Buy” and a consensus target price of $18.60.

About Lantheus Holdings

Lantheus Holdings, Inc is engaged in the development, manufacture and commercialization of diagnostic medical imaging agents and products that assist clinicians in the diagnosis and treatment of cardiovascular and other diseases. Its imaging agents and products are used across a range of imaging modalities, including echocardiography and nuclear imaging.

Insider Buying and Selling by Quarter for Lantheus Holdings (NASDAQ:LNTH)

Receive News & Ratings for Lantheus Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lantheus Holdings Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.